MLN4924 inhibits the growth of human xenograft models of DLBCL. CB.17 SCID mice bearing OCI-Ly10 (A) and OCI-Ly19 (B) were dosed by subcutaneous administration with either vehicle control or MLN4924 on the doses and schedules indicated. Mean tumor volume ± SEM are shown (n = 10 mice per group).